Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia

Authors

Naseema Gangat
Kristen McCullough
Maymona Abdelmagid
Omer Karrar
Marissa Z. Powell, Henry Ford HealthFollow
Aref Al-Kali
Hassan Alkhateeb
Kebede Begna
Abhishek Mangaonkar
Antoine Saliba
Mehrdad H. Torghabeh
Mark Litzow
William Hogan
Mithun Shah
Mrinal Patnaik
Animesh Pardanani
Talha Badar
James Foran
Jeanne Palmer
Lisa Sproat
Cecilia A. Yi
Ayalew Tefferi

Recommended Citation

Gangat N, McCullough K, Abdelmagid M, Karrar O, Powell M, Al-Kali A, Alkhateeb H, Begna K, Mangaonkar A, Saliba A, Torghabeh MH, Litzow M, Hogan W, Shah M, Patnaik M, Pardanani A, Badar T, Foran J, Palmer J, Sproat L, Yi CA, and Tefferi A. Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia. Haematologica 2023.

Document Type

Article

Publication Date

8-3-2023

Publication Title

Haematologica

Medical Subject Headings

Humans; Leukemia; Myeloid; Acute/drug therapy/genetics; Enzyme Inhibitors/pharmacology; Isocitrate Dehydrogenase/genetics; Mutation

PubMed ID

37534525

ePublication

ePub ahead of print

Volume

109

Issue

1

First Page

187

Last Page

292